Vaibhav Sinha joins Indoco Remedies

Published On 2024-11-06 07:33 GMT   |   Update On 2024-11-06 07:33 GMT
Advertisement

Mumbai: Indoco Remedies has announced the appointment of Vaibhav Sinha as Senior Management Personnel designated as Vice President- Business Development-Rest of the World of the Company with effect from 05th November, 2024.

Vaibhav Sinha is a commerce graduate and has completed MBA in International Business from Delhi School of Economics and PG Diploma in Finance from Institute of Management Sciences. He has 19+ years industry experience with global companies like
Sun Pharma,
Ranbaxy and DSM with exposure to multiple product segments and markets. He was last employed with Sun Pharma as Head of Business Development, Licensing, Portfolio and Acquisitions (Asia and Africa). He has expertise in licensing (In/Out), M&A, portfolio planning, new launches, business strategy and analysis, techno commercial due diligence, deal structuring with hands on exposure of working for NCEs, Biologics/Biosimilars, Rx, OTC and complex products.

Indoco is a fully integrated, research-oriented pharmaceutical company with presence in 55 countries. The Company’s turnover is US$ 200 million. The Company has 9 manufacturing facilities, 6 for FDFs and 3 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. The facilities have been approved by most of the Regulatory Authorities including USFDA and UK-MHRA. Indoco develops and manufactures a wide range of pharmaceutical products for the Indian and international markets. It generates more than 107 million prescriptions annually from over 2,30,000 doctors belonging to various specialties. Indoco has 9 domestic marketing divisions with a brand portfolio in various therapeutic segments including Gastro-intestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management, Gynecology, etc. Top Indoco brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, SensodentKF, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM 69, Methycal, Homide, Cal-Aid, etc. On the international front, Indoco has tie-ups with large generic companies across the globe.

Read also: Indoco Remedies receives USFDA approval for allergy drug Cetirizine Hydrochloride

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News